WASHINGTON, March 29 (Reuters) - Medtronic Inc's minimally invasive CoreValve system for replacing diseased aortic heart valves led to a significantly higher survival rate after one year than ...
Nontransfemoral implantation, however, was not an independent predictor of mortality and likely reflected the higher risk of the patients treated this way. What's to Be Gleaned From UK TAVI? Speaking ...
Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...
Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...
ANN ARBOR, Mich. – The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to ...
CHICAGO, IL — The largest-ever review of transcatheter aortic-valve replacement (TAVR) procedures for failed bioprosthetic valves suggests that TAVR could play a key role in solving a problem that ...
"With the number of aortic valve stenosis patients steadily rising as the Japanese population ages, we consider this an important step towards the introduction of a new therapeutic option to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results